英文别名：
()-2-fluoro-α(1)-2-Fluoro-alpha-methyl(1,1'-biphenyl)-4-acetic acid;(2R)-2-(2-fluorobiphenyl-4-yl)propanoate;(2S)-2-(2-fluorobiphenyl-4-yl)propanoate;FLURBIPROFEN;-methyl[1,1'-biphenyl]-4-acetic acid;5104-49-4;alpha-methyl-2-fluoro-4-biphenylylacetic acid;SR-01000003043;5GRO578KLP;HMS3371I05;NSC-685701;(+/-)-2-(2-FLUORO-4-BIPHENYLYL)PROPIONIC ACID;KBio3_001270;HMS3393A05;SMR000042823;HMS2051A05;HMS3649K11;Flurbiprofen O;(1,1'-Biphenyl)-4-acetic acid, 2-fluoro-alpha-methyl-, (+/-)-;2-(2-fluoro-[1,1'-biphenyl-4-yl])propanoic acid;FLURBIPROFEN [ORANGE BOOK];SCHEMBL10029029;NSC-755404;Spectrum2_001025;NSC 757037;NCGC00025287-03;UNII-5GRO578KLP;2-(2-fluoro-(1,1'-biphenyl-4-yl))propanoic acid;CHEMBL563;2-Fluoro-alpha-methyl-4-biphenylacetic acid;HMS2091F21;NC00563;M01AE09;FP 70;[1,1'-Biphenyl]-4-acetic acid, 2-fluoro-.alpha.-methyl-;FT-0771103;F0371;KBio2_004144;SPECTRUM1500308;SPBio_002983;U-27,182;Froben;NCGC00018157-11;MLS000040873;BRD-A86044036-001-05-9;(+-)-2-(2-Fluoro-4-biphenylyl)propionic acid;NSC685701;NCGC00018157-13;[1,1'-Biphenyl]-4-acetic acid, 2-fluoro-?-methyl-;BDBM50074922;BCP09086;2-Fluoro-alpha-methyl-[1,1'-biphenyl]-4-a cetic acid;Prestwick0_000917;FLURBIPROFEN [USAN];AO-295/42284050;(S)-(+)-2-Fluoro-alpha-methyl-4-biphenylaceticacid;Flurbiprofen, United States Pharmacopeia (USP) Reference Standard;CAS-5104-49-4;Flurbiprofen (NSAID);Ansaid;FLURBIPROFEN [USP-RS];(.+/-.)-Flurbiprofen;BSPBio_002050;FLURBIPROFEN [INN];FT-0603668;NS00003058;Fluriproben;Q-201129;FT-0660285;(.+/-.)-2-Fluoro-.alpha.-methyl-4-biphenylacetic acid;HY-10582;(2RS)-2-(2-Fluorobiphenyl-4-yl)propanoic acid;(1,1'-Biphenyl)-4-acetic acid, 2-fluoro-alpha-methyl-;CCG-40243;MPC7869;(1,1'-Biphenyl)-4-acetic acid, 2-fluoro-alpha-methyl-, (+-)-;2 -(2-fluoro-4-biphenylyl)propionic acid;HMS3414N17;HB3049;2-(2-Fluorobiphenyl-4-yl)propionic Acid;FLURBIPROFEN [USP MONOGRAPH];Opera_ID_777;Z2216885233;Prestwick2_000917;C15H13FO2;HMS3268E10;BIM-0051387.0001;2-fluoro-alpha-methyl-(1,1''-biphenyl)-4-acetic acid;Flurbiprofene [INN-French];Yakuban;2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid;HMS1570H16;HMS2232I08;SR-01000003043-5;FLURBIPROFEN [MART.];C07013;NC00009;(.+/-.)-2-(2-Fluoro-4-biphenylyl)propionic acid;NSC-757037;MFCD00079303;Flurbiprofen [USAN:USP:INN:BAN:JAN];Spectrum3_000435;BSPBio_000794;HMS3714H16;Tox21_110547;AB00051999;MKS-11;FLURBIPROFEN (USP MONOGRAPH);(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid;DTXCID8017231;Zepolas;Flurbiprofene (INN-French);KBioGR_001255;BPBio1_000874;HMS502I06;CHEBI:5130;MLS006011431;2-FLUORO-[1,1'-BIPHENYL]-4-(ALPHA-METHYL)ACETIC ACID;MLS000028441;BCP13426;SR-01000003043-6;SR-01000003043-14;SYTBZMRGLBWNTM-UHFFFAOYSA-;Stayban;Prestwick1_000917;2-Fluoro-?-methyl-[1,1'-biphenyl]-4-acetic acid;2-(3-fluoro-4-phenyl-phenyl)propanoic acid;SBI-0051387.P003;FT-0668760;S01BC04;MLS006011931;(RS)-2-(2-fluorobiphenyl-4-yl)propionic acid;NCGC00018157-03;EINECS 257-262-6;51543-38-5;2-(2-fluorobiphenyl-4-yl)propanoic acid;KBio2_001576;KBio2_006712;R02AX01;(+/-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid;SR-01000003043-2;FLURBIPROFEN [WHO-DD];HMS2090I06;DB00712;Flubiprofen;2(2-Fluoro-4-biphenylyl)propionic acid;(+-)Flurbiprofen;2-(2-fluoro-4-biphenylyl)-propionic acid;Flurbiprofen - CAS 5104-49-4;DTXSID0037231;MLS001201729;Antiphlamine Pain Relieving;DivK1c_000804;2-Fluoro-.alpha.-methyl-4-biphenylacetic acid;Flurbiprofen, Antibiotic for Culture Media Use Only;dl-Flurbiprofen;EINECS 225-827-6;[1,1'-Biphenyl]-4-acetic acid, 2-fluoro-a-methyl-, (A+/-)-;Flurbiprofeno [INN-Spanish];FLURBIPROFEN [EP MONOGRAPH];2-Fluoro-.alpha.-methyl(1,1'-biphenyl)-4-acetic acid;Flurbiprofen, European Pharmacopoeia (EP) Reference Standard;NSC755404;4-Biphenylacetic acid, 2-fluoro-.alpha.-methyl-;Ocuflur;HMS3655G19;2-(2-Fluoro[1,1'-biphenyl]-4-yl)propanoic acid;SCHEMBL2248;HMS1920O20;BTS 18,322;KBioSS_001576;Ocufen;GTPL4194;Flurbiprofen, cyclooxygenase inhibitor;U 27182;U 27,182;AB00051999_18;Q419890;AC-8106;Flurbiprofen (USAN:USP:INN:BAN:JAN);FLURBIPROFEN [MI];Flurbiprofenum (INN-Latin);MLS001401361;NCGC00018157-05;HMS2097H16;Prestwick3_000917;EN300-7479231;Flurbiprofenum;FLURBIPROFEN (USP-RS);FLP;(R)-Flurbiprofen;MPC7869;(+/-)-2-FLUORO-.ALPHA.-METHYL-4-BIPHENYLACETIC ACID;FLURBIPROFEN [JAN];Flurbiprofen,(S);HMS3370N14;Flurbiprofen (JP17/USP/INN);KBio1_000804;2-(2-FLUORO-[1,1'-BIPHENYL]-4-YL)PROPANOIC ACID;2-(2-Fluoro-1,1'-biphenyl-4-yl)propanoic acid;NCGC00016654-01;D00330;M02AA19;Tox21_302353;Flurbiprofen (Ansaid);AKOS016340701;Flurbiprofen, Pharmaceutical Secondary Standard; Certified Reference Material;4-Biphenylacetic acid, 2-fluoro-alpha-methyl-;Flurbiprofeno (INN-Spanish);Flurbiprofen; (2RS)-2-(2-Fluorobiphenyl-4-yl)propanoic acid;Cebutid;rac-Flurbiprofen;NCGC00018157-08;2-(2-fluoro-[1,1''-biphenyl-4-yl])propanoic acid;BTS 18322;Pharmakon1600-01500308;Flurbiprofene;U-27182;2-(3-fluoro-4-phenylphenyl)propanoic acid;HMS3678N15;(1,1'-BIPHENYL)-4-ACETIC ACID, 2-FLUORO-.ALPHA.-METHYL-, (+/-)-;Adfeed;MLS000758198;Anmetarin;HMS3259I12;NCGC00255457-01;3-Fluoro-4-phenylhydratropic acid;L-790,330;2-(2-fluoro-biphenyl-4-yl)propionic acid;2-(2-Fluoro-4-biphenylyl)propionic acid;2-(2-Fluoro[1,1'-biphenyl]-4-yl)propanoic acid #;Spectrum5_000720;KS-5035;Flugalin;NSC757037;[1,1'-Biphenyl]-4-acetic acid, 2-fluoro-.alpha.-methyl-, (.+/-.)-;CCRIS 3708;CCG-100759;BTS-18322;Ansaid (TN);2-fluoro--methyl-(1,1'-biphenyl)-4-acetic acid;Spectrum_001096;AB00051999-17;InChI=1/C15H13FO2/c1-10(15(17)18)12-7-8-13(14(16)9-12)11-5-3-2-4-6-11/h2-10H,1H3,(H,17,18);IDI1_000804;(r/s)-2-fluoro-alpha-methyl-4-biphenylacetic acid;FLURBIPROFEN (EP MONOGRAPH);SPBio_001209;NINDS_000804;FLURBIPROFEN [VANDF];2-Fluoro-alpha-methyl(1,1'-biphenyl)-4-acetic acid;Spectrum4_000558;Flurbiprofeno;2-(2-fluoro-biphenyl-4-yl)-propionic acid;NCGC00025287-04;FLURBIPROFEN (MART.);Flurbiprofenum [INN-Latin];NCGC00018157-04;NCI60_030812;AKOS004119934;Ocufen (Salt/Mix);Flurofen;Antadys;
3418426269 
